Top 20 of Diabetes Complications

Article title # Publications/# Citations

Biochemistry and molecular cell biology of diabetic complications.

2001: MBrownlee;


Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

2010: American Heart Association Statistics Committee and Stroke Statistics Subcommittee; RJAdams; JDBerry; TMBrown; MRCarnethon; SDai; Gde Simone; ESFord; ... CSFox; HJFullerton; CGillespie; ASGo; KJGreenlund; SMHailpern; JAHeit; PMHo; VJHoward; BMKissela; SJKittner; DTLackland; JHLichtman; LDLisabeth; DMLloyd-Jones; DMMakuc; GMMarcus; AMarelli; DBMatchar; MMMcDermott; JBMeigs; CSMoy; DMozaffarian; MEMussolino; GNichol; NPPaynter; VLRoger; WDRosamond; PDSorlie; RSStafford; TNTuran; MBTurner; NDWong; JWylie-Rosett;


Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

2004 Sep 11-17: INTERHEART Study Investigators; AAvezum; ABudaj; TDans; SHawken; FLanas; LLisheng; MMcQueen; ... SOunpuu; PPais; JVarigos; SYusuf;


Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.



Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

2003: VSBales; BABowman; WHDietz; ESFord; JSMarks; AHMokdad; FVinicor;


Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

2000: JBosch; GDagenais; RDavies; JPogue; PSleight; SYusuf;


Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

2007: HBEl-Serag; KLRudolph;


The pathobiology of diabetic complications: a unifying mechanism.

2005: MBrownlee;


Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

1990: WPCastelli; RJGarrison; WBKannel; DLevy; DDSavage;


Standards of medical care in diabetes--2011.

2011: American Diabetes Association;


The prevalence of comorbid depression in adults with diabetes: a meta-analysis.

2001: RJAnderson; REClouse; KEFreedland; PJLustman;


Standards of medical care in diabetes--2012.

2012: American Diabetes Association;


Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

2002: LIFE Study Group; GBeevers; BDahlöf; Ude Faire; RBDevereux; FFyhrquist; HIbsen; SJulius; ... SEKjeldsen; KKristiansson; OLederballe-Pedersen; LHLindholm; MSNieminen; POmvik; SOparil; HWedel;


Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

1993: JDNeaton; JStamler; OVaccaro; DWentworth;


International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

2009: International Expert Committee;


Diabetes and cardiovascular disease. The Framingham study.

1979: WBKannel; DLMcGee;


A potential decline in life expectancy in the United States in the 21st century.

2005: DBAllison; JBrody; RNButler; BACarnes; LHayflick; RCHershow; JLayden; DSLudwig; SJOlshansky; DJPassaro;


Economic costs of diabetes in the U.S. In 2007.

2008: American Diabetes Association;


MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

2003: Heart Protection Study Collaborative Group; JArmitage; RCollins; SParish; RPeto; PSleigh;


Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

1999: LYAgodoa; VBAshby; REEttenger; PJHeld; ELMilford; AOOjo; FKPort; RAWolfe;